Type
Closure
Country
United Kingdom
Region
Scotland; Eastern Scotland; Angus and Dundee City
Location of affected unit(s)
Montrose
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

300 jobs
Number of planned job losses
Job loss
Announcement Date
7 October 2004
Employment effect (start)
Foreseen end date
31 December 2006

Description

The Glaxosmithkline Montrose site in Scotland, is to shut by the end of 2006 with the loss of 300 jobs. Jim Mowatt, T&G National Secretary for manufacturing, said: ‘We are deeply disappointed by GSK's announcement that it intends to shut its Montrose site. This is a world-class site serviced by a world-class workforce, and we believe that the search for a suitable purchaser should begin immediately. The shop stewards and members have demonstrated a tremendous degree of flexibility and willingness to meet all the company's demands, so we are especially disappointed by the news.'


Sources

  • 7 October 2004: Transport and General Workers' Union news
  • 7 October 2004: BBC News

Citation

Eurofound (2004), Glaxo Smith Kline, Closure in United Kingdom, factsheet number 60647, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60647.